Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model
Saved in:
| Main Authors: | Deanna M. Marchionini, Stef De Lombaerde, Joëlle van Rijswijk, Franziska Zajicek, Liesbeth Everix, Alan Miranda, Mari J. Aaltonen, Carleen M. Kluger, Thomas Wild, Aglaia Kakoulidou, Jannis Gundelach, Tim Fieblinger, Joachim Fentz, Jim Rosinski, John Obenauer, Jonathan R. Greene, Longbin Liu, Ignacio Munoz-Sanjuan, Marleen Verhoye, Jeroen Verhaeghe, Jonathan Bard, Steven Staelens, Daniele Bertoglio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Neurobiology of Disease |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996125001226 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biodistribution and dosimetry of the PET radioligand [18F]CHDI-650 in mice for detection of mutant huntingtin aggregates
by: Jordy Akkermans, et al.
Published: (2024-12-01) -
Assessment of changes in synaptic density in the zQ175DN mouse model of Huntington’s disease: a [18F]SynVesT-1 study
by: Liesbeth Everix, et al.
Published: (2025-01-01) -
mTOR inhibition in Q175 Huntington’s disease model mice facilitates neuronal autophagy and mutant huntingtin clearance
by: Philip Stavrides, et al.
Published: (2025-05-01) -
Huntingtin plays an essential role in the adult hippocampus
by: Jessica C. Barron, et al.
Published: (2025-03-01) -
Deletion of the huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice.
by: Shuqiu Zheng, et al.
Published: (2010-02-01)